Nextil Expands Into U.S. Medical Market with Majority Stake in Isavela

Nextil moves forward in the United States. The Spanish company has signed a memorandum of understanding with the US company Isavela Enterprises, which specializes in the design, manufacture and marketing of compression and post-surgical garments for the medical sector. With this agreement, Nextil acquires a 51% majority stake in the group.

As reported by the Spanish company to the Comisión Nacional del Mercado de Valores (Cnmv), the Mou includes a future option to acquire 100% of Isavela, in a transaction whose value has not been disclosed.

“The potential integration of Isavela would allow Nextil to complete the value chain in the medical segment, from fabric development to the final garment,“ the company said in a statement.

Nextil posted a net profit of €1.2 million in the first half of the current financial year, after years of losses

Following the transaction, Isavela will continue to operate independently, under the leadership of its current executive team, while receiving the industrial, technological and commercial boost from Nextil to accelerate its expansion in the United States, its main market, as well as globally.

Isavela currently has an annual recurring turnover of between $10 million and $11 million, with an Ebitda of over $3 million.

At the end of November, Nextil signed a binding strategic agreement with the U.S.-based Maxum International Group, dedicated to third-party production, for the launch and international distribution of NextGreen, an industrial solution that integrates complete circularity, natural dyeing and end-to-end production. The agreement established a minimum projection of $200 million over five years.

After years of losses, the company began to see the first signs of recovery a few months ago. In the first half of the current financial year, the company increased its net profit 17-fold to €1.2 million and posted a turnover of €16.3 million, which is 20% more than in the first half of 2024. Nextil has also managed to reduce its net debt to 12 million euros, compared to more than €50 million at the end of 2023.